跳至主要内容
临床试验/IRCT20171030037093N28
IRCT20171030037093N28招募中3 期

Comparative study of therapeutic effect and side effects of enoxaparin with UFH in pregnant patients with mechanical prosthetic heart valves at their first 14 weeks of pregnancy

Esfahan University of Medical Sciences0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • No drug allergy to any of the drugs studied
  • No history of recurrent miscarriage or stillbirth associated with antiphospholipid syndrome
  • Being monitored by the researcher from the beginning of pregnancy
  • Having Class I or II heart disease
  • Having a metal heart valve
  • Having a pregnancy week of 14 weeks or less

排除标准

  • Non-cooperation after inclusion
  • Lack of access to the patient and follow-up
  • Forced to terminate pregnancy immediately
  • Warfarin use in the first 3 months
  • Patients not able to follow up anti-10a factor
  • Thrombocytopenia (less than 75,000)

研究者

相似试验